BackKiromic BioPharma Overview

Kiromic BioPharma Research & Development

Research & Development expenses for KRBP.

Quarterly R&D Expenses

$-4531000.00
↓ 255.91% YoY

As of Dec 31, 2024

Annual R&D Expenses (TTM)

$6.85M
↓ 28.79% YoY

Trailing 12 months ending Dec 31, 2024

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin